Key result
Early data evaluate percutaneous venous valve bioprostheses for safety and efficacy in chronic deep venous insufficiency.
Why the study?
Most patients with chronic deep venous insufficiency are not candidates for direct deep vein valve repair or valve transplantation, and percutaneous venous valve bioprosthesis may improve venous hemodynamics.
Does a percutaneous venous valve bioprosthesis provide safety, patency, and efficacy in patients with chronic deep venous insufficiency?
Design
Phase I trial of percutaneous venous valve bioprosthesis
Authors
Loading...
Does not support clinical use; leaves open the safety and efficacy of percutaneous venous valve bioprosthesis in chronic deep venous insufficiency.
Does a percutaneous venous valve bioprosthesis provide safety, patency, and efficacy in patients with chronic deep venous insufficiency?
Initial observations from a Phase I trial suggest the feasibility of evaluating a percutaneous venous valve bioprosthesis for chronic deep venous insufficiency.
Gale et al. (2004) studied Chronic deep venous insufficiency (n=2). Percutaneous venous valve bioprosthesis was evaluated on Safety, patency, and efficacy to restore competency to the deep venous system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: